KAYFANDA

Medicinal product

(Invented) name

KAYFANDA

Active substance (s)

Odeviksibatas

Strength

400 mg

Pharmaceutical form

kietosios kapsulės

Route (s) of administration

vartoti per burną

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

A05AX05, odevixibat

Marketing authorisation holder

Ipsen Pharma, Prancūzija

Date of authorisation

2024-09-19

Date of renewal

Documents

Search in EMA Europe

Stage

Registruotas

Controlled?

No

Controlled substance type

Legal basis

8(3)

Procedure number

Marketing authorisation procedure

Centrinė registracija

Qualitative and quantitative composition

Kapsulėje yra:	1 vnt.
Odeviksibatas	400 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
115185	101294	1101294	buteliukas	N30		Receptinis	EU/1/24/1854/002	Netiekiama	-	-	No	-	-

Stadijos

Data	Stadija
2024-09-19	Registruotas